SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is shown to prevent severe illness and death in hemodialysis (HD) patients, but the immune response to vaccines is reduced in this population. This study compared SARS-CoV-2 spike protein antibody titers between HD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanai, Daisuke, Wakui, Hiromichi, Haze, Tatsuya, Azushima, Kengo, Kinguchi, Sho, Tsukamoto, Shunichiro, Kanaoka, Tomohiko, Urate, Shingo, Toya, Yoshiyuki, Hirawa, Nobuhito, Kato, Hideaki, Watanabe, Fumimasa, Hanaoka, Kanako, Hanaoka, Masaaki, Mitsuhashi, Hiroshi, Yamaguchi, Satoshi, Ohnishi, Toshimasa, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244285/
https://www.ncbi.nlm.nih.gov/pubmed/35751753
http://dx.doi.org/10.1007/s10157-022-02243-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244285/
https://www.ncbi.nlm.nih.gov/pubmed/35751753
http://dx.doi.org/10.1007/s10157-022-02243-8

Ejemplares similares